EU MDR
The route to the European market, and a known bottleneck. We help you plan around it so timelines stay realistic and value holds.
Regulatory strategy
Regulation as a growth lever
For investors and institutions, regulation is a risk to navigate and a lever for value, not a technical hurdle we drill into here. We help you read the pathways, sequence them well, and turn approval into a competitive edge.
01 The pathways
Three frameworks, one strategy
Three frameworks shape where a medtech venture can sell and how fast it gets there. We help you choose them, sequence them, and weigh what each means for time, cost and confidence. The detail sits with your technical teams; the strategy sits with us.
FDA
The gateway to the largest medtech market. The right pathway shapes cost and speed, and a clear plan lifts investor confidence early.
ISO 13485
The quality foundation buyers and regulators expect. Built well, it de-risks diligence and signals a venture ready to scale.
Regulation done well de-risks an investment and accelerates growth. A clear pathway shortens time to market, controls cost, and gives every backer confidence in what comes next.
The next step
Turn regulation into an edge.
Tell us about the venture or portfolio and the markets in view. We will map the regulatory strategy that protects value and speeds growth, in plain terms, built for the decisions you face.